Rx-to-OTC Switch Series
Kline's Rx-to-OTC Switch series is well-regarded for providing subscribers with objective, independent forecasts of future Rx-to-OTC switches and their expected impacts on the OTC market. Our analyses provide forecasts of future switches in existing OTC categories and projections for new OTC categories. These forecasts are based on Kline's own primary research with OTC and Rx executives, retailers, regulators, and other stakeholders. These reports provide comparative analyses of prescription and over-the-counter markets, regulatory issues, safety/efficacy issues, potential OTC indications and claims, likelihood of switch and expected timing, OTC market potential and sales forecasts, expected competitive response including OTC branded and private-label strategies.
Rx-to-OTC Switch Forecasts USA 2010 Please click here for full description
Published April 2010
Rx-to-OTC-Switch Strategies USA Please click here for full description
Published November 2007
Rx-to-OTC Switch: The Next Wave Please click here for full description
Published December 2002
International Rx-to-OTC Switch Forecasts Please click here for full description
Published October 2005
U.S. Cholesterol-Lowering Drugs 2005: Rx Market Analysis and Switch Forecasts Please click here for full description
Published November 2005
History and Impact of the Rx-to-OTC Switch 1996 Please click here for full description
Published April 1996
Contact
|
